Article

Rep. Frank Pallone Jr. on the Impetus for the 21st Century Cures Act

Author(s):

Rep. Frank Pallone Jr.

Rep. Frank Pallone Jr., Sixth Congressional District of New Jersey, House Energy and Commerce Committee, discusses the impetus for the 21st Century Cures Act.

Rep. Frank Pallone Jr., Sixth Congressional District of New Jersey, House Energy and Commerce Committee, discusses the impetus for the 21st Century Cures Act.

Newsletter

Stay up to date on cancer updates, research and education

Subscribe Now!
Related Videos
Illustration of doctor.
Breaking Down the Stigma and How to Better Understand Rare Blood Cancers
Image of doctor.
Patient and Disease-Related Factors Influence Outcomes in Urothelial Cancer
Image of man with black hair.
Investigating the Addition of Surgery to ICI Therapy in Kidney Cancer
Picture of Dr. Pouneh Razavi
Breast MRI Offers Sensitive Imaging for High-Risk and Diagnosed Patients
Richard Winneker gathers input from patients and researchers to shape MPN research, aiming to fund strategic projects for this population.
How an Advocate Unites Voices to Guide MPN Research Decisions
Dr. Curtiland Deville Jr. discusses the importance of crafting an individualized treatment plan for patients with prostate cancer.
Crafting an Individual Treatment Plan for Patients With Prostate Cancer
Image of Crispino
Working to Address Unmet Medical Needs in MPNs
Image of Dr. Reznick
How to Best Navigate a Diagnosis of Lung and Head and Neck Cancer
Picture of Joy Anderson
Joy Anderson Reflects on Her Diagnosis of a Rare Blood Cancer
Some patients with relapsed/refractory diffuse large B-cell lymphoma whose disease progressed after CAR-T cell therapy, responded to odronextamab.
Odronextamab Elicits Responses in Some With Lymphoma Following CAR-T
Related Content
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
April 11th 2025

What Role May ctDNA Have in Melanoma Management?

Dr. Michael K. Wong
CURE spoke with Dr. Michael K. Wong and Dr. Diwakar Davar about the use of ctDNA for patients with melanoma, and where the field may be headed.
image of dr. Lillian Siu.
April 3rd 2025

Breaking Down Early Signs and Symptoms of Head and Neck Cancer

Dr Lillian Siu
April is Head and Neck Cancer Awareness Month, and it is important to be aware of early signs and symptoms of the disease, as well as when to seek care.
Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer
March 6th 2025

Artificial Intelligence Enhances Polyp Detection in Colorectal Cancer

Ryan Scott
Artificial intelligence aids in polyp detection, enhancing colonoscopy effectiveness and reducing the risk of colorectal cancer progression in patients.
Image of Dr. Fakih.
February 27th 2025

ctDNA Alone ‘Not Sufficient’ When Monitoring Patients With Colorectal Cancer

Dr. Marwan Fakih
The addition of ctDNA testing to radiographic surveillance resulted in curative surgical intervention for 1.6% of patients with colorectal cancer.
Image of doctor with brown hair.
February 25th 2025

Some KRAS Mutations Associated With Worse Outcomes in Pancreatic Cancer

Dr. Vaia Florou
In patients with pancreatic ductal adenocarcinoma, KRAS G12D and G12V mutations hare associated with worse patient outcomes, researchers have found.
Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment.
February 21st 2025

How Patients With Cancer Can Avoid Counterfeit Therapeutics Online

Dr. Megan Menon
Dr. Megan Menon explains how patients can verify the authenticity of online prescription purchases for their cancer treatment.